Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoMix 30 vs Mixtard 30 in Type 2 Diabetes
NCT01467401Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2002
- Primary completion
- May 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2002; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01467401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467401.